AQR Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $505K | Sell |
434,958
-184,372
| -30% | -$214K | ﹤0.01% | 2609 |
|
|
2025
Q1 | $985K | Buy |
619,330
+396,233
| +178% | +$630K | ﹤0.01% | 2022 |
|
|
2024
Q4 | $676K | Buy |
223,097
+27,615
| +14% | +$83.7K | ﹤0.01% | 2097 |
|
|
2024
Q3 | $719K | Buy |
+195,482
| New | +$719K | ﹤0.01% | 2010 |
|
|
2022
Q2 | – | Sell |
-4,517
| Closed | -$208K | – | 2313 |
|
|
2022
Q1 | $208K | Sell |
4,517
-2,725
| -38% | -$125K | ﹤0.01% | 2052 |
|
|
2021
Q4 | $609K | Buy |
+7,242
| New | +$609K | ﹤0.01% | 1765 |
|